A
LIVE

Serial Number

79378177

Owner

Axplora Group GmbH

Attorney

B. Michelle Alvey

Filing Date

Apr 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

A Trademark

Serial Number: 79378177 • Registration: 7813350

A is a trademark filed by Axplora Group GmbH on April 13, 2023. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Axplora Group GmbH (3 trademarks)

Hochstraß Süd 7

Entity Type: 27

Trademark Details

Filing Date

April 13, 2023

Registration Date

June 3, 2025

Published for Opposition

April 15, 2025

Goods & Services

Contract manufacturing of pharmaceutical and chemicals and their components for third parties; contract manufacturing of pharmaceuticals, chemicals and biopharmaceuticals; custom manufacturing of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides, and other therapeutic biomolecules; custom manufacturing on a pilot and commercial scale of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides and other therapeutic biomolecules; custom manufacturing in the nature of processing of functional food and food ingredients; custom manufacturing in the nature of processing on pilot and commercial scale of functional food and food ingredients; custom manufacturing of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; custom manufacturing on a pilot and commercial scale of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; custom manufacturing of chemicals through chemical syntheses; processing of biochemicals through the synthesis of biological products for customers in the food, chemical, agricultural, veterinary and pharmaceutical industries; custom synthesis of intermediate products in the nature of intermediate organic products for industrial purposes for the food, chemical, agricultural, veterinary, and pharmaceutical industries; contract manufacturing of hazardous products being glycerol trinitrate, azides, explosives and other industrial chemicals for third parties; contract custom manufacturing of substitution aromates and chiral molecules for use in synthesis of products for others for third parties; preparation of galenic formulations for others, namely, custom manufacture of pharmaceuticals by pharmaceutical compounders

Unprocessed chemical products, namely, unprocessed plastics, unprocessed polymers, unprocessed artificial resins; biochemical catalysts, catalysts for chemical and biochemical processes, catalysts for use in the manufacture of industrial chemicals; chemical reagents for non-medical purposes; chemical additives for use in the manufacture of pharmaceuticals, agrochemicals, cosmetics, food products, and polymers; chemical products as chemical synthesis intermediates for industrial purposes; active chemical ingredients for use in manufacture of pharmaceuticals, agrochemicals, cosmetics, food products, and polymers; hemi synthesis products, namely, semi-synthesized chemical products for use in biotechnological product development; fertilizers; chemical products as intermediates for the production of pharmaceutical, veterinary, medical and cosmetic active ingredients

Providing quality control, namely, analytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing products, notably for the food, chemical, agricultural, veterinary, pharmaceutical industries; scientific research in the field of galenic forms, specifically for others

Purified essential oil extracts, for industrial use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries

Pharmaceutical, veterinary, sanitary products, namely, steroids, diuretic preparations, anti-inflammatory preparations, dietary supplements, nutritional supplements, diagnostic agents for medical purposes being visualization agents for use during colonoscopies, contraceptive preparations, preparations for the treatment of burns, pharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agent, pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; fungicides, herbicides, insecticides, and pesticides

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2026 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 5, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 5, 2026 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 3, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2025 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 8, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 19, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 13, 2024 NREP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2024 CNRT
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 6, 2023 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 3, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2023 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 12, 2023 MAFR
ASSIGNED TO EXAMINER
Sep 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2023 REPR